FMC continues to face crop protection destocking pressure with generic competition eroding diamides franchise margins. Channel inventory normalization has taken longer than guided. Biologicals segment growth helpful but not enough to offset legacy headwinds. Patent expirations on key products tighten the medium-term outlook.
Thesis reviewed May 29, 2026
FMC Corporation is headquartered in United States, which is currently showing moderate signals.
🇺🇸United States66NEUTRALView United States risk detail →🌾Agriculture21REDUCE| Ticker | Company | Score | Gap | Signal Δ | Action |
|---|---|---|---|---|---|
| BG | Bunge Global SA | 27 | +12% | ↓51% | EARLY |
| ADM | Archer-Daniels-Midland Company | 27 | +4% | ↓51% | NEUTRAL |
| CAG | Conagra Brands Inc. | 27 | -10% | ↓51% | AVOID |
| GIS | General Mills Inc. | 27 | -9% | ↓51% | AVOID |
| DOLE | Dole plc | 27 | +13% | ↓51% | EARLY |
| FMC | FMC Corporation | 27 | -6% | ↓51% | AVOID |
| HUL | Hindustan Unilever Ltd. | 27 | +3% | ↓51% | NEUTRAL |
Investors who hold FMC may also have indirect exposure through these country funds.
FMC lowers FY26 guidance citing pricing pressure on diamides
Generic chlorantraniliprole supply expands into Brazil season
Estimates · Yahoo Finance · Not audited figures
| Politician | Party | Type | Amount | Trade Date | Return |
|---|---|---|---|---|---|
| Dan NewhouseWA | Buy | $1k–$15k | Jul 10, 26 |